KINSHASA, Democratic Republic of the Congo / RankWire.AI / – Health authorities in the Democratic Republic of the Congo began administering Ebola vaccinations in Kisangani on Thursday, launching a targeted campaign in the capital of Tshopo Province to protect frontline responders. The initiative prioritizes healthcare workers, emergency response teams, and individuals with direct contact with confirmed patients as the country confronts its deadliest recorded Ebola outbreak. Health Minister Samuel-Roger Kamba confirmed that the government deployed an initial supply of the Ervebo vaccine under a compassionate-use framework across impacted eastern provinces to safeguard essential personnel and help disrupt viral transmission chains.
Official epidemiological data indicates that the ongoing outbreak has spread across six eastern provinces, including Ituri, North Kivu, South Kivu, Tshopo, Haut-Uele, and Bas-Uele. Public health figures published by the Ministry of Public Health and Prevention show that the country has recorded 5,713 confirmed cases and 2,744 deaths. The current overall case fatality rate among confirmed patients stands at approximately 48%.
In response to the health emergency, international health agencies, including the World Health Organization, are providing logistical support, laboratory testing, and vaccine distribution efforts. Authorities are administering the Ervebo vaccine under a compassionate-use framework while medical researchers gather observational data on its effectiveness against the viral strain circulating in the region. DR Congo launches Ebola vaccination campaign as health workers intensify ring-vaccination strategies around identified infection clusters to isolate viral transmission chains.
Health Ministry Focuses on Allocating Ervebo Doses to Frontline Healthcare Personnel in Kisangani
Operational challenges, including complex regional infrastructure, ongoing security issues, and high mobility across border districts, complicate logistical efforts. Kisangani has established cold-chain networks to preserve the vaccine’s required ultra-low temperatures before distribution to more remote health zones. The Ebola vaccination campaign is underway, with civil defense and community health workers conducting outreach to enhance disease surveillance and reporting systems.
Collaborations between epidemiologists from the Africa Centres for Disease Control and Prevention and local response units are ongoing to monitor adverse events and assess immune responses among vaccinated populations. Officials highlighted that early clinical detection, along with isolation protocols and supportive treatment, remains critical for improving patient survival rates. Additional vaccine shipments are planned as regional distribution extends into secondary health districts.
Infection Control Standards Heightened at Treatment Facilities by Health Authorities
Contact-tracing efforts are expanding across urban centers and rural areas in the eastern regions by national response teams. Health centers are receiving personal protective equipment, diagnostic reagents, and therapeutics to bolster preparedness. The government confirmed that comprehensive public health measures will stay in place until viral transmission rates show consistent decline across all affected provinces.
Communities are urged by the government to cooperate fully with mobile vaccination teams and follow sanitary protocols. Increased immunization among high-risk groups is expected to stabilize infection rates over the coming weeks. Surveillance networks will maintain vigilant monitoring at transportation hubs and border crossings to prevent further spread geographically.